| Original language | English |
|---|---|
| Pages (from-to) | 571-583 |
| Number of pages | 13 |
| Journal | Eur. Child Adolesc. Psychiatry |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- Attention-deficit/hyperactivity disorder (ADHD)
- Behavior
- Cognition
- Docosahexaenoic acid (DHA)
- Fatty acids
- docosahexaenoic acid
- placebo
- adolescent
- Article
- attention deficit disorder
- behavior
- behavior assessment
- child
- clinical article
- cognition
- controlled study
- diet supplementation
- fatty acid blood level
- female
- human
- male
- patient compliance
- quality of life
- randomized controlled trial
- rating scale
- social psychology
- attention
- child behavior
- child parent relation
- dietary supplement
- double blind procedure
- drug effect
- physiology
- psychology
- treatment outcome
- Adolescent
- Attention
- Attention Deficit Disorder with Hyperactivity
- Child
- Child Behavior
- Dietary Supplements
- Docosahexaenoic Acids
- Double-Blind Method
- Female
- Humans
- Male
- Parents
- Quality of Life
- Treatment Outcome
Cite this
Crippa, A., Tesei, A., Sangiorgio, F., Salandi, A., Trabattoni, S., Grazioli, S., Agostoni, C., Molteni, M., & Nobile, M. (2019). Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial: European Child and Adolescent Psychiatry. Eur. Child Adolesc. Psychiatry, 28(4), 571-583. https://doi.org/10.1007/s00787-018-1223-z